INS and small cell lung carcinoma: And for KEGG analysis, the top five descriptions were prostate cancer (hsa05215), the insulin signaling pathway (hsa04910), small-cell lung cancer (hsa05222), the adipocytokine signaling pathway (hsa04920), and the glucagon signaling pathway (hsa04922).